The biotech industry is experiencing steady growth as a result of rapid drug development and, the growing impact of chronic diseases, and the development of innovative therapies and treatments that are revolutionizing healthcare.
Given the industry’s growth prospects, investors could consider buying fundamentally sound biotech stocks Entrada Therapeutics, Inc. (TRDA), Alkermes plc (ALKS) and Amgen Inc. (AMGN) for solid returns.
